EGR1/ <i>LINC00839</i> /SOX5 axis modulates migration, invasion and Gemcitabine resistance of bladder cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EGR1/ LINC00839 /SOX5 axis modulates migration, invasion and Gemcitabine resistance of bladder cancer cells

Published:2023-10-20 Issue:1 Volume:24 Page:
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Wang Zunxian¹²,Wei Bo³,Ma Shuxia¹^ORCID

Affiliation:

1. Basic Medical College, Jiamusi University, Jiamusi, Heilongjiang, China

2. Department of Oncology Comprehensive Treatment, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang, China

3. Department of Urology, The First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang, China

Funder

Scientific Research Funding of Jiamusi University

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2023.2270106

Reference39 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. The dynamic roles of the bladder tumour microenvironment

3. LINC00839 promotes colorectal cancer progression by recruiting RUVBL1 /Tip60 complexes to activate NRF1

4. Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling

5. LINC00839/miR-144-3p/WTAP (WT1 Associated protein) axis is involved in regulating hepatocellular carcinoma progression

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics;Cancer Letters;2024-06

2. Biological functions and therapeutic potential of SRY related high mobility group box 5 in human cancer;Frontiers in Oncology;2024-05-21

3. LINC00839 in Human Disorders: Insights into its Regulatory Roles and Clinical Impact, with a Special Focus on Cancer;Journal of Cancer;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3